{
    "clinical_study": {
        "@rank": "117778", 
        "acronym": "MORE-CRT MPP", 
        "arm_group": [
            {
                "arm_group_label": "MPP ON", 
                "arm_group_type": "Experimental", 
                "description": "MPP ON: feature is enabled"
            }, 
            {
                "arm_group_label": "MPP OFF", 
                "arm_group_type": "No Intervention", 
                "description": "MPP OFF: feature not enabled"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this Clinical investigation is to assess the impact of the Multi Point Pacing\n      (MPP) feature at 12 months in the treatment of patients not responding to standard Cardiac\n      Resynchronization Therapy (CRT) after 6 months."
        }, 
        "brief_title": "MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing", 
        "completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Meets the current ESC Guidelines or ACCF/AHA/HRS Class I or Class IIa indications for\n             CRT implant (including upgrades from single or dual chamber ICDs)\n\n          -  Must be willing and able to comply with study requirements\n\n          -  Must indicate their understanding of the study and willingness to participate by\n             signing an appropriate informed consent form\n\n        Exclusion Criteria:\n\n          -  Already had a CRT device implanted\n\n          -  Myocardial Infarction, unstable angina within 40 days prior the enrollment\n\n          -  Recent cardiac revascularization (PTCA, Stent or CABG) in the 4 weeks prior to\n             enrollment or planned for the 3 months following\n\n          -  Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) in the 3 months\n             prior the enrollment\n\n          -  Primary valvular disease\n\n          -  Persistent Atrial Fibrillation\n\n          -  Unable to comply with the follow up schedule\n\n          -  Less than 18 years of age\n\n          -  Pregnant or are planning to become pregnant during the duration of the investigation\n\n          -  Classification of Status 1 for cardiac transplantation or consideration for\n             transplantation over the next 12 months\n\n          -  Undergone a cardiac transplantation\n\n          -  Life expectancy < 12 months\n\n          -  Currently participating in any other clinical investigation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1256", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02006069", 
            "org_study_id": "CR-13-006-ID-HF"
        }, 
        "intervention": {
            "arm_group_label": "MPP ON", 
            "description": "All patients enrolled in the study will be implanted (according to current Guidelines) with an MPP compatible CRT device", 
            "intervention_name": "MPP", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "CRT, non responders, MultiPoint Pacing (MPP)", 
        "lastchanged_date": "February 26, 2014", 
        "location": {
            "contact": {
                "email": "r.e.knops@amc.uva.nl", 
                "last_name": "Reinhoud Knops, MD", 
                "phone": "0031318583250"
            }, 
            "facility": {
                "address": {
                    "city": "Amsterdam", 
                    "country": "Netherlands"
                }, 
                "name": "Amsterdam Academic Medical Center (AMC)"
            }, 
            "investigator": {
                "last_name": "Reinhoud Knops, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "2", 
        "official_title": "MOre REsponse on Cardiac Resynchronization Therapy (CRT) With MultiPoint Pacing (MPP)", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Institutional Ethical Committee", 
                "Italy: Ethics Committee", 
                "Germany: Ethics Commission"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint of this study is evaluated at 12 months after enrollment and it is defined as the percentage of non-responder patients converted to responders after 6 months of MPP feature turned ON compared to baseline, as measured by Left Ventricular End Systolic Volume (LVESV) reduction of at least 15%.", 
            "measure": "CRT Response", 
            "safety_issue": "No", 
            "time_frame": "Response to CRT after 6 months of MPP"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02006069"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Reduction of LVESV between baseline and 6 Months visit", 
                "measure": "Reduction of LVESV in acute phase", 
                "safety_issue": "No", 
                "time_frame": "Baseline vs 6 Months"
            }, 
            {
                "description": "Packer's Clinical Composite Score evaluation between baseline and 12 months and between 6 and 12 months", 
                "measure": "Clinical Composite Score evaluation", 
                "safety_issue": "No", 
                "time_frame": "Baseline vs 12 Months"
            }, 
            {
                "description": "Evaluation of Reverse LV remodeling, measured as changed in echo values LVESV, LVEDD and LVEF", 
                "measure": "Reverse LV remodeling", 
                "safety_issue": "No", 
                "time_frame": "Baseline vs 12 Months"
            }, 
            {
                "description": "Evaluation of NYHA Class changes between Baseline and 12 Months FU", 
                "measure": "NYHA Class changes", 
                "safety_issue": "No", 
                "time_frame": "Baseline vs 12 Months"
            }, 
            {
                "description": "Evaluation of the patient's activity status using 6 Minutes Walking Test changes from baseline to 12 months FU", 
                "measure": "6MWT changes", 
                "safety_issue": "No", 
                "time_frame": "Baseline vs 12 Months"
            }, 
            {
                "description": "Evaluation of patient's Quality of Life score using Minnesota Living with Heart Failure (MLWHF) and EQ-5D Questionnaires", 
                "measure": "Patient's QoL score changes (MLWHF, EQ-5D)", 
                "safety_issue": "No", 
                "time_frame": "Baseline vs 12 Months"
            }
        ], 
        "source": "St. Jude Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Jude Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}